Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|15|1767-1784

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.15, 2004-06, pp. : 1767-1784

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of phosphoinositide 3-kinase inhibitors

By Drees Beth E   Mills Gordon B   Rommel Christian   Prestwich Glenn D  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 703-732

Informa Healthcare

Access to resources Recommend Favorite

Pyrrolo[2,3]pyrimidine inhibitors of Janus kinase 3 protein tyrosine kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. : 1087-1092

Informa Healthcare

Access to resources Recommend Favorite

QSAR and Molecular Docking Studies on a Series of 1-Amino-5H-pyrido [4, 3-b]indol-4-carboxamides Acting as Janus Kinase 2 (JAK2) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 15, Iss. 2, 2018-01 ,pp. : 169-180

Bentham Science Publishers

Access to resources Recommend Favorite

Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 268-294

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational Janus kinase inhibitors

By Tam Constantine S  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 687-699

Informa Healthcare

Access to resources Recommend Favorite